Durabilidad de la bioprótesis Trifecta™ a medio plazo: experiencia de un centro

Durabilidad de la bioprótesis Trifecta™ a medio plazo: experiencia de un centro

Resumen: Introducción y objetivos: Aunque la bioprótesis aórtica Trifecta™ (Abbott Vascular, Santa Clara, California) presenta un buen comportamiento hemodinámico a corto plazo, se ha descrito un aumento de deterioro estructural precoz. El objetivo principal de nuestro estudio es analizar la incide...

Full description

Bibliographic Details
Main Authors:	Lourdes Montero-Cruces, Manuel Carnero-Alcázar, Daniel Pérez-Camargo, Fernando José Reguillo Lacruz, Francisco J. Cobiella-Carnicer, Luis C. Maroto-Castellanos
Format:	Article
Language:	Spanish
Published:	Elsevier 2022-09-01
Series:	Cirugía Cardiovascular
Subjects:	Bioprosthesis Structural valve deterioration Aortic valve
Online Access:	http://www.sciencedirect.com/science/article/pii/S1134009622001528

Similar Items

Sustitución valvular aórtica con bioprótesis convencionales o sin sutura: resultados clínicos y comportamiento hemodinámico a 3 años
by: María A. Giraldo-Molano, et al.
Published: (2023-05-01)

Mid-Term Clinical Outcomes and Hemodynamic Performances of Trifecta and Perimount Bioprostheses following Aortic Valve Replacement
by: Francesca Toto, et al.
Published: (2023-03-01)

Perceval or Trifecta to Prevent Patient–Prosthesis Mismatch
by: Daniel Hernandez-Vaquero, et al.
Published: (2020-09-01)

Resultados clínicos y consumo de recursos tras sustitución valvular aórtica con prótesis biológicas o mecánicas en pacientes de 65 años o más
by: Daniel Pérez-Camargo, et al.
Published: (2023-01-01)

Transcatheter “valve-in-valve” implantation of bioprosthesis in failed surgical tricuspid bioprosthesis (first experience in Russia)
by: T. E. Imaev, et al.
Published: (2019-03-01)

Hemodynamic and Clinical Outcomes in Redo-Surgical Aortic Valve Replacement vs. Transcatheter Valve-in-Valve
by: Sébastien Hecht, MSc, et al.
Published: (2022-11-01)

One-Year Hemodynamic Performance of Three Cardiac Aortic Bioprostheses: A Randomized Comparative Clinical Trial
by: Lourdes Montero-Cruces, et al.
Published: (2021-11-01)

Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses
by: Rüdiger Lange, et al.
Published: (2022-01-01)

Experiencia de un centro en el reemplazo percutáneo de la válvula mitral mediante el dispositivo Tendyne™
by: Lourdes Montero-Cruces, et al.
Published: (2022-09-01)

Prevention by the CXCR2 antagonist SCH527123 of the calcification of porcine heart valve cusps implanted subcutaneously in rats
by: Yuthiline Chabry, et al.
Published: (2023-09-01)

Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity
by: Farhad Waziri, et al.
Published: (2019-03-01)

Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteriaCentral MessagePerspective
by: Stéphane Kermen, MD, et al.
Published: (2022-09-01)

Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study
by: Gopichand Mannam, et al.
Published: (2018-09-01)

Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient
by: Marco Zanobini, et al.
Published: (2017-12-01)

Impact of postoperative patient-prosthesis mismatch as a risk factor for early structural valve deterioration after aortic valve replacement with Trifecta bioprosthesis
by: Tatsuto Wakami, et al.
Published: (2022-07-01)

Conventional vs. Sutureless Aortic Valve Bioprosthesis: Is Faster Better?
by: Ali Aljalloud, et al.
Published: (2023-07-01)

Bioprosthesis in the Mitral Position: Bovine Pericardial versus Porcine Xenograft
by: Dong Youb Han, et al.
Published: (2022-02-01)

Transcatheter Aortic Valve-in-Valve Implantation Complicated by Aorto-Right Ventricular Fistula
by: Tiffany Patterson, MBBS, PhD, et al.
Published: (2020-02-01)

Reparaciones mitrales en España entre 2001 y 2015: Análisis del Conjunto Mínimo Básico de Datos Nacional
by: Manuel Carnero-Alcázar, et al.
Published: (2022-10-01)

EARLY DEGENERATED BIOPROSTHETIC MITRAL VALVE
by: Irina-Mihaela Ciomaga, et al.
Published: (2014-09-01)

Transcatheter Mitral Valve-in-Valve Implantation with the Balloon-Expandable Myval Device
by: Sara Blasco-Turrión, et al.
Published: (2022-09-01)

Initial experience with the Perceval S sutureless aortic valve
by: Tatjana Raickovic, et al.
Published: (2020-04-01)

Hemodynamic Performance of Pericardial Bioprostheses in the Aortic Position
by: Haeju Lee, et al.
Published: (2020-10-01)

Editorial: Structural Valve Degeneration and Failure in Transcatheter and Surgical Bioprosthesis
by: Chiara Fraccaro, et al.
Published: (2020-04-01)

Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration
by: Matteo Marro, et al.
Published: (2021-02-01)

Transcatheter Mitral Valve-in-Valve Implantation Applying a Long Pre-Curved Sheath for Patients with Degenerated Bioprosthetic Mitral Valve
by: Yang Liu, et al.
Published: (2023-02-01)

Valve-in-valve transcatheter aortic valve replacement on a self-expandable nitinol frame due to degeneration of primary bioprosthetic valve cusps. Clinical case of a high-risk surgical female patient
by: L. S. Kokov, et al.
Published: (2020-10-01)

Early calcific degeneration of the St. Jude Medical Epic aortic bioprosthesis
by: Mohammad Bashar Izzat, et al.
Published: (2020-02-01)

An Analysis of Early Results after Valve Replacement in Isolated Aortic Valve Stenosis by Using Sutureless vs. Stented Bioprostheses: A Single-Center Middle-Income Country Experience
by: Marko Kaitovic, et al.
Published: (2023-05-01)

“Valve-On-Valve” — an alternative method of surgical treatment of tissue valve dysfunctions
by: N. V. Rogulina, et al.
Published: (2019-09-01)

Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years
by: Jun Yu, et al.
Published: (2022-05-01)

Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis
by: Walter J. Gomes, et al.
Published: (2015-10-01)

Thrombocytopenia among Patients Undergoing Aortic Valve Replacement Using the Sutureless Perceval S Bioprosthesis: A Retrospective Study
by: Adrien Jayet, et al.
Published: (2024-02-01)

Left Main Protection During very High Risk Transcatheter Aortic Valve-in-Valve Procedure. A Collaborative Registry
by: Luca Testa, et al.
Published: (2016-01-01)

Mid to Long-term Echocardiographic Follow-up of Patients Undergoing Transcatheter Tricuspid Valve-in-Valve Replacement for Degenerated Bioprosthetic Valves: First Single-Center Report from Iran
by: Mohammad Sahebjam, et al.
Published: (2022-07-01)

The first transcatheter valve-in-valve implantation of a self-expandable valve for the treatment of a degenerated sutureless aortic bioprosthesis
by: I. Kosmas, et al.
Published: (2020-01-01)

Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
by: Do Jung Kim, et al.
Published: (2018-02-01)

A rare case report of early bioprosthetic valve thrombosis presenting with acute heart failure salvaged by thrombectomy
by: Jingya Fan, et al.
Published: (2017-03-01)

Successful fracture of a trifecta bioprosthetic aortic valve
by: Panagiotis Savvoulidis, et al.
Published: (2023-05-01)

A propensity matched analysis of outcomes and long term survival in stented versus stentless valves
by: Blake N. Shultz, et al.
Published: (2017-05-01)